Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
hepatitis A vaccine (inactivated) (Vabiotech)
- Development stage
- Unknown
- Lead developer
- Vabiotech
- Modality
- Vaccines & Immunotherapeutics
- Administration
- Intramuscular
01
Overview
HAVAX is an inactivated hepatitis A vaccine developed and manufactured by **Vabiotech** (Company for Vaccine and Biological Production No.1) in Vietnam. It is the first hepatitis A vaccine to be produced domestically in Vietnam. The vaccine is prepared from the hepatitis A virus (HAV) grown in human diploid cell cultures (MRC-5), which is subsequently purified, inactivated with formaldehyde, and adsorbed onto an aluminum hydroxide adjuvant. HAVAX is designed to stimulate active immunity by inducing the production of specific neutralizing anti-HAV antibodies, thereby preventing infection by the hepatitis A virus. It is approved for use in both pediatric (from 12 months of age) and adult populations, typically administered as a two-dose primary series.
- Brand names
- HAVAX
- Other names
- Hepatitis A vaccineInactivated Hepatitis A vaccineVabiotech Hepatitis A vaccine
02
Targets
Hepatitis A virus capsid protein
Beyond the preview
Go deeper on hepatitis A vaccine (inactivated) (Vabiotech).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on hepatitis A vaccine (inactivated) (Vabiotech).